· 2022–2024 · DOL EFAST2
Search
Browse
Resources
Pricing
NORDIC PHARMA, INC. — NORDIC PHARMA, INC., 401(K) PROFIT SHARING PLAN, Form 5500 (2024) | Form 5500 Search
Back to filter
Original filing (PDF)
20251015153213NAL0002674579001
NORDIC PHARMA, INC.
Form 5500-SF
FILING_RECEIVED
NORDIC PHARMA, INC., 401(K) PROFIT SHARING PLAN
401(k) retirement plan
Active participants
15
Accounts w/ balance
21
Plan assets (EOY)
$4.0M
Net assets (EOY)
$4.0M
Plan health score (directional)
89
/ 100
Grade A
Top-tier plan health
Directional indicator computed from public Form 5500 data — compliance, concentration, cost, vendor stack and participation. Not a fiduciary tool.
Compliance & disclosures
100
Concentration risk
75
Total plan cost
75
Vendor stack
100
Participation health
Decision-maker contacts
CFO / Head of HR / Benefits Manager — verified email + LinkedIn for
NORDIC PHARMA, INC.
.
Find decision makers
Plan sponsor
Name
NORDIC PHARMA, INC.
EIN
47-1604786
Address
1205 WESTLAKES DRIVE · SUITE 275 · BERWYN, PA · 19312
Phone
(844) 304-4828
Industry
Manufacturing
see all
Plan administrator
Same as plan sponsor.
Plan characteristics
Plan number
001
Plan year
2024
Plan year begin
2024-01-01
Tax period
2024-12-31
Filed
2025-10-15
Pension benefit codes
2A · Age/service weighted or new comparability
2E · Profit-sharing
2F · ERISA section 404(c)
2G · Total participant-directed accounts
2J · 401(k) feature
2K · 401(m) arrangement
2S · Automatic enrollment
2T · Default investment account (QDIA)
Service providers (Schedule C)
Small plans don't disclose service providers
Related plans
Similar-size Manufacturing plans
FERA PHARMACEUTICALS, LLC
FERA PHARMA 401(K) PROFIT SHARING PLAN
$3.9M · 14 participants
BONUM THERAPEUTICS, INC.
BONUM THERAPEUTICS 401(K) PLAN
$4.0M · 34 participants
NATURES VALUE INC.
NATURE'S VALUE INC. 401(K) AND PROFIT SHARING PLAN
$4.0M · 233 participants
NUSANO, INC
NUSANO, INC. 401(K) PLAN
$4.0M · 152 participants
SEPTERNA INC.
SEPTERNA INC. 401(K) PLAN
$4.0M · 76 participants
100
Helping the score
Concentration not scored — Schedule of Assets PDF not yet parsed for this plan.
No Schedule C compensation disclosed — likely a small plan or unbundled.
3D · Pre-approved plan (master / prototype / VS)
Audit & trust (Schedule H)
Auditor
—
Trustee / custodian
—
Trustee phone
—
Small plan (5500-SF) — Schedule H data not available.
TERGUS PHARMA, LLC
TERGUS PHARMA, LLC 401(K) PLAN
$4.1M · 46 participants
Large plans in Pennsylvania
VANGUARD FIDUCIARY TRUST COMPANY
VANGUARD FIDUCIARY TRUST COMPANY INSTITUTIONAL TOTAL INTERNATIONAL STOCK MARKET INDEX TRUST II
$223.1B
VANGUARD FIDUCIARY TRUST COMPANY
VFTC INSTITUTIONAL 500 INDEX TRUST
$183.5B
VANGUARD FIDUCIARY TRUST COMPANY
VANGUARD FIDUCIARY TRUST COMPANY TARGET RETIREMENT 2035 MASTER TRUST
$116.3B
VANGUARD FIDUCIARY TRUST COMPANY
VANGUARD FIDUCIARY TRUST COMPANY TARGET RETIREMENT 2045 MASTER TRUST
$109.4B
VANGUARD FIDUCIARY TRUST COMPANY
VANGUARD FIDUCIARY TRUST COMPANY TARGET RETIREMENT 2040 MASTER TRUST
$108.2B
VANGUARD FIDUCIARY TRUST COMPANY
VANGUARD FIDUCIARY TRUST COMPANY TARGET RETIREMENT 2030 MASTER TRUST
$106.2B